| Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Substudies
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
Multi-center, prospective observational cohort study of individuals with congenital heart defects (CHD). Phenotypic data and source DNA derived from 10,000 probands, parents, and families of interest are being collected to investigate relationships between genetic factors and phenotypic and clinical outcomes in patients with CHD. Phenotype data will be stored at dbGaP, while molecular and sequence data will be stored at BioData Catalyst.
The PCGC Cohort is utilized in the following dbGaP substudies. Please click on the following substudies below or in the "Substudies" section of this top-level study page phs001194 PCGC Cohort.
- phs000571 PCGC: whole exome sequences, whole genome sequences, targeted sequences, MIP sequences, and SNP array data
- phs001843 PCGC-CMG Collaboration: whole genome sequences
The Gabriella Miller Kids First Pediatric Research Program (Kids First) subset of the PCGC project (phs001194) is now accessible through a separate dbGaP study accession: phs001138. To access this dataset, please submit a Data Access Request (DAR) for phs001138. Approval of this DAR will be expedited for approved users of phs001194. To learn about other Kids First datasets visit https://kidsfirstdrc.org/.
NHLBI's TOPMed program has provided additional Whole Genome Sequencing for PCGC participants - that data is accessible through a separate dbGaP sudy accession: phs001735. Access to this data set should be requested through a Data Access Request (DAR) for phs001735.
- Study Weblinks:
- Study Design:
- Prospective Longitudinal Cohort
- Study Type:
- Cohort
- Parent-Offspring Trios
- Total number of consented subjects: 21963
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data
- Link to other NCBI resources related to this study
-
- BioProject
- PubMed
- Sequence Read Archive
- PMC
- Clinical Trials
- Study Inclusion/Exclusion Criteria
Inclusion criteria:
- Age 0 - 99 years of age
- Males and females
- No ethnic or race restrictions
- Sporadic and familial cases are included
- Pregnant women who have a fetus with diagnosed CHD
Exclusion Criteria:
- Isolated patent foramen ovale
- Isolated prematurity-associated patent ductus arteriosus
- Lack of consent
- Study History
November 2010: First study visit
November 2011: First annual follow-up visit for probands ≤ 1 yr
July 2013: dbGaP data release of 1,955 subjects
September 2014: dbGaP addendum: additional 1,325 subjects
January 2016: dbGaP addendum: additional 2,985 subjects
September 2016: dbGaP addendum: additional 3,186 subjects
December 2018: dbGaP addendum: additional 4,270 subjects
January 2024: dbGaP addendum: additional 8,250 subjects- Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: Heart Defects, Congenital
- Authorized Data Access Requests
-
See articles in PMC citing this study accession
- Study Attribution
-
-
Funding Sources
- UM1 HL098162 (Yale PCGC). National Heart Lung and Blood Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
- UM1 HL098123 (Sinai PCGC). National Heart Lung and Blood Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
- U01 HL131003 (ACC). National Heart Lung and Blood Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
- UM1 HL098147 (Boston PCGC). National Heart Lung and Blood Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
- UM1 HL128711 (Utah PCGC). National Heart Lung and Blood Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
- UM1 HL128761 (UCSF PCGC). National Heart Lung and Blood Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
- U01 HL153009 (Columbia/Sinai PCGC). National Heart Lung and Blood Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
- 5U01HL098153 (CHOP PCGC). National Heart Lung and Blood Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
-
Funding Sources